Differential regulation of interleukin 1 receptor and toll-like receptor signaling by MEKK3

Nature Immunology

Volumn 5, Issue 1, 2004, Pages 98-103

  Huang, Qiaojia ^a   Yang, Jianhua ^a   Lin, Yong ^b   Walker, Christopher ^a   Cheng, Jinke ^a   Liu, Zheng Gang ^b   Su, Bing ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NUCLEAR FACTOR; PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; EMBRYO; GENE CONTROL; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-6; MALE; MAP KINASE KINASE KINASE 3; MAP KINASE KINASE KINASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PRECIPITIN TESTS; PROTEIN KINASES; PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 0346496017     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1014     Document Type: Article

References (35)

1. Dunne, A. & O'Neill, L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE2003, re3 (2003).
2. Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335-376 (2003).
3. Akira, S. & Hemmi, H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85, 85-95 (2003).
4. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol.1, 135-145 (2001).
5. Medzhitov, R. & Janeway, C. Jr. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173, 89-97 (2000).
6. Takeuchi, O. & Akira, S. Toll-like receptors; their physiological role and signal transduction system. Int. Immunopharmacol. 1, 625-635 (2001).
7. Takeuchi, 0. & Akira, S. MyD88 as a bottle neck in Toll/IL-1 signaling. Curr. Top Microbiol. Immunol. 270, 155-167 (2002).
8. Janeway, C.A. Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
9. Yamamoto, M. et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-b promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668-6672 (2002).
10. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 (2003).
11. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & Seya, T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-b induction. Nat. Immunol. 4, 161-167 (2003).
12. Hoebe, K. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743-748 (2003).
13. Ninomiya-Tsuji, J. et al. The kinase TAK1 can activate the NIK-IkB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252-256 (1999).
14. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
15. Kopp, E. et al. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13, 2059-2071 (1999).
16. Lee, F.S., Hagler, J., Chen, Z.J. & Maniatis, T. Activation of the IkBa kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88, 213-222 (1997).
17. Baud, V. et al. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13, 1297-1308 (1999).
18. Zhao, Q. & Lee, F.S. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kB through IkB kinase-a and IkB kinase-b. J. Biol. Chem. 274, 8355-8358 (1999).
19. Yang, J. et al. The essential role of MEKK3 in TNF-induced NF-kB activation. Nat. Immunol. 2, 620-624 (2001).
20. Malinin, N.L., Boldin, M.P., Kovalenko, A.V. & Wallach, D. MAP3K-related kinase involved in NF-kB induction by TNF, CD95 and IL-1. Nature 385, 540-544 (1997).
21. Dumitru, C.D. et al. TNF-a induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083 (2000).
22. Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu. Rev. Immunol. 18, 621-663 (2000).
23. Karin, M. & Delhase, M. JNK or IKK, AP-1 or NF-kB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. USA 95, 9067-9069 (1998).
24. Ghosh, S. & Karin, M. Missing pieces in the NF-kB puzzle. Cell 109, S81-96 (2002).
25. Xia, Y. et al. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. USA 97, 5243-5248 (2000).
26. Shinkura, R. et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-kb-inducing kinase. Nat. Genet. 22, 74-77 (1999).
27. Yin, L. et al. Defective lymphotoxin-b receptor-induced NF-kB transcriptional activity in NIK-deficient mice. Science 291, 2162-2165 (2001).
28. Sanjo, H. et al. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Mol. Cell Biol. 23, 1231-1238 (2003).
29. Blank, J.L., Gerwins, R, Elliott, E.M., Sather, S. & Johnson, G.L. Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J. Biol. Chem. 271, 5361-5368 (1996).
30. Ellinger-Ziegelbauer, H., Brown, K., Kelly, K. & Siebenlist, U. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem. 272, 2668-2674 (1997).
31. Su, B., Cheng, J., Yang, J. & Guo, Z. MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression. J. Biol. Chem. 276, 14784-14790(2001).
32. Yang, J. et al. Mekk3 is essential for early embryonic cardiovascular development. Nat. Genet. 24, 309-313 (2000).
33. Guo, Z. et al. Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction. Mol. Cell Biol. 22, 5761-5768 (2002).
34. Takaesu, G. et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAP-KKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell. 5, 649-658 (2000).
35. Naviaux, R.K., Costanzi, E., Haas, M. & Verma, I.M. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70, 5701-5705(1996).